Yu‐Lueng Shih

机构：Tri-Service General Hospital, Taichung Armed Forces General Hospital, National Defense Medical Center · ORCID：0000-0003-4629-4393

发表论文 132 篇 · 总被引 2538 次 · h-index 27

代表论文

Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection (2024 · Journal of Hepatology · 被引 34)
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan (2023 · Hepatology International · 被引 21)
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study (2022 · Open Forum Infectious Diseases · 被引 18)
Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals (2024 · Journal of Gastroenterology · 被引 15)
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison (2022 · World Journal of Gastroenterology · 被引 14)
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection (2025 · Alimentary Pharmacology & Therapeutics · 被引 12)